查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1419128

心输出量监测设备市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按产品、类型、最终用户和地理位置

Cardiac Output Monitoring Devices Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, Type, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 150 Pages | 商品交期: 1-5个工作天内

价格
简介目录

心输出量监测设备市场预计将从2022年的14.98亿美元成长到2030年的22.15亿美元；预计2022年至2030年CAGR为5.0%。

心臟左心室或右心室在一分钟内泵出的血液量称为心输出量。它依赖于每搏输出量和心率。生物阻抗、脉搏轮廓分析、热稀释、FloTrac 监测、PiCCO 心输出量监测、多普勒和 Ficks 原理是心输出量监测技术的基础。使用心输出量监测设备对于评估手术室、重症监护室和其他环境中的患者非常重要。由于技术的发展，锂稀释方法使连续即时心输出量 (CO) 监测成为可能。在整个预测期内，心输出量监测设备市场预计将经历该技术的指数级成长。

容易心血管疾病的老年人口不断增加，推动了心输出量监测设备市场的成长。

心血管疾病（CVD）和其他需要持续监测和重症监护的重大健康问题在老年族群中越来越常见。 CVD 的几个主要危险因子是年龄、种族和家族史。吸烟、患有高血压、高胆固醇、肥胖、缺乏运动、患有糖尿病、饮食不良和饮酒是其他危险因子。

因此，在估计期间，世界人口老化预计将推动心输出量监测设备市场。根据世界卫生组织（WHO）预测，到2030年，全球60岁以上人口将达14亿。随着年龄的增长，人们变得更容易受到行动限制的影响，因此他们需要医疗援助或援助以避免对其他人的依赖。全球人口正在迅速老化，预计未来几年老年人数将大幅增加。根据2020年人口普查，美国65岁及以上人口的成长速度比1920-2020年整体人口成长速度近五倍。 2020年，65岁以上的美国人有5,580万，占总人口的16.8%。此外，巴西 13% 的人口（超过 3,000 万名老年人）年龄在 60 岁或以上；到2030年，这一人口预计将达到5,000万左右，即占全国人口的24%。因此，容易患心血管疾病的老年人口的增加是心输出量监测设备市场成长的重要驱动力。

另一方面，患者和医疗保健专业人员特别担心设备中的网路安全缺陷，尤其是电脑影像撷取设备 (CIED) 等设备，这些设备有可能被重新编程或变得无法操作。美国食品药物管理局 (FDA) 于 2023 年表示，美敦力 (Medtronic) 召回了约 35 万个植入式心臟设备，因为这些设备在需要时提供高压治疗的能力始终存在问题。

FDA 网站上的一份建议指出，“低能量电击或根本不进行电击可能无法纠正危及生命的心律失常，从而导致心臟骤停、其他严重伤害或死亡。” “如果携带其中一种设备的患者需要额外的外科手术来移除和更换该设备，则会存在额外的伤害风险。”本次召回涵盖 2017 年后生产的所有带有玻璃馈通的心臟再同步治疗除颤器 (CRT-D) 和植入式心律转復除颤器 (ICD)。 FDA 表示，使用这些设备“可能会导致严重伤害或死亡”，并将其列为 I 级召回。因此，市场的成长将受到一定程度的限制。

心输出量监测设备市场根据产品、类型和最终用户进行细分。市场依产品分为消耗品、配件和仪器。按类型划分，心输出量监测设备市场分为侵入式和非侵入式。最终用户将心输出量监测设备市场细分为医院、门诊手术中心等。依地理位置，心输出量监测设备市场分为北美（美国、加拿大和墨西哥）、欧洲（英国、德国、法国、义大利、西班牙和欧洲其他地区）、亚太地区（中国、日本、印度） 、韩国、澳洲和亚太地区其他地区）、中东和非洲（阿联酋、沙乌地阿拉伯、南非以及中东和非洲其他地区）以及南美洲和中美洲（巴西、阿根廷以及南美洲和非洲其他地区）中美洲）。

根据地理位置，心输出量监测设备市场分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。北美是心输出量监测设备成长的最重要贡献者。该地区的成长归因于多种因素，包括药物开发公司投资的增加、美国政府的大量拨款、大型药物开发公司的强大影响力、发达的医疗基础设施以及慢性病的增加。

根据地理位置，心输出量监测设备市场主要分为北美、欧洲、亚太地区、中东和非洲以及南美洲和中美洲。北美是全球市场成长的最重要贡献者。就全球心输出量监测设备市场而言，北美在2021年占据最大份额。这可以归因于心血管疾病盛行率的上升、医疗保健成本的增加、可支配收入的增加、健康意识的提高、以及切割的可及性

疾病管制与预防中心 (CDC) 和食品药物管理局 (FDA) 是准备心输出量监测设备报告时参考的主要主要和次要来源。

目录

第 1 章：简介

  • 研究范围
  • 市场定义、假设与限制
  • 市场区隔

第 2 章：执行摘要

  • 重要见解
  • 市场吸引力分析

第 3 章：研究方法

第 4 章：心输出量监测设备市场格局

  • 概述
  • PEST分析
  • 生态系分析
    • 价值链供应商名单

第 5 章：心输出量监测设备市场 - 主要市场动态

  • 主要市场驱动因素
  • 主要市场限制
  • 主要市场机会
  • 未来的趋势
  • 驱动因素和限制因素的影响分析

第 6 章：心输出量监测设备市场 - 全球市场分析

  • 心输出量监测设备 - 全球市场概览
  • 心输出量监测设备 - 全球市场与 2030 年预测

第 7 章：心输出量监测设备市场 - 收入分析 - 按产品，2020-2030 年

  • 概述
  • 耗材及配件
  • 仪器

第 8 章：心输出量监测设备市场 - 收入分析 - 按类型，2020-2030 年

  • 概述
  • 侵入性
  • 非侵入性

第 9 章：心输出量监测设备市场 - 收入分析 - 按最终用户，2020-2030 年

  • 概述
  • 医院
  • 门诊手术中心
  • 其他的

第 10 章：心输出量监测设备市场 - 收入分析，2020-2030 - 地理分析

  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥

註 - 将为以下提到的地区/国家提供类似的分析

  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 欧洲其他地区
  • 亚太
    • 澳洲
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 11 章：Covid-19 前后的影响

第 12 章：产业格局

  • 併购
  • 协议、合作、合资企业
  • 新产品发布
  • 扩张和其他策略发展

第13章：竞争格局

  • 关键参与者的热图分析
  • 公司定位与专注

第 14 章：心输出量监测设备市场 - 主要公司简介

  • Getinge AB

注意 - 将为以下公司列表提供类似信息

  • 通用电气医疗集团
  • ICU 医疗公司
  • 百特国际公司
  • 爱德华生命科学公司
  • LiDCO集团有限公司
  • 德尔泰克斯医疗集团有限公司
  • 美国通信委员会
  • 奥西普卡医疗股份有限公司
  • CNSystems 医疗技术有限公司

第 15 章：附录

  • 词彙表
  • 关于 Insight Partners
  • 市场情报云
简介目录
Product Code: TIPRE00011437

The cardiac output monitoring devices market is expected to grow from US$ 1.498 billion in 2022 to US$ 2.215 billion by 2030; it is anticipated to record a CAGR of 5.0% from 2022 to 2030.

The amount of blood pumped by the heart's left or right ventricle in a minute is known as cardiac output. It is reliant on both stroke volume and heart rate. Bioimpedance, pulse contour analysis, thermodilution, FloTrac monitoring, PiCCO cardiac output monitoring, Doppler, and the Ficks principle are the foundations of cardiac output monitoring techniques. Using cardiac output monitoring devices is important in assessing patients in the operating room, critical care unit, and other settings. Thanks to technological developments, the lithium dilution approach has made continuous real-time cardiac output (CO) monitoring possible. Throughout the projection period, the market for cardiac output monitoring devices is anticipated to experience exponential growth for this technique.

The increasing geriatric population prone to CVD drives the growth of the cardiac output monitoring devices market.

Cardiovascular diseases (CVDs) and other significant health issues that require constant monitoring and intensive care are increasingly common in the senior population. A few main risk factors for CVD are age, ethnicity, and family history. Using smoke, having high blood pressure (hypertension), having high cholesterol, being obese, being inactive, having diabetes, having a poor diet, and drinking alcohol are additional risk factors.

As a result, over the estimated period, the world's aging population is expected to drive the cardiac output monitoring device market. According to World Health Organization (WHO) projections, by 2030, there will be 1.4 billion persons over 60 worldwide. With age, people become more susceptible to mobility limitations, as a result of which they require medical assistance or aid to avoid dependence on other individuals. The global population is aging rapidly, and the number of older adults is expected to increase significantly in the coming years. According to the 2020 Census, in the US, the population aged 65 and above surged nearly five times faster than the overall population growth during 1920-2020. In 2020, 55.8 million Americans, i.e., 16.8% of the total population, were aged 65 and above. Further, 13% of Brazil's population-more than 30 million seniors-is aged 60 or more; this population is expected to reach ~50 million by 2030, i.e., 24% of the country's population. Thus, the increasing geriatric population prone to CVD is a significant driver for the growth of the cardiac output monitoring devices market.

On the other hand, patients and healthcare professionals are particularly concerned about cybersecurity flaws in devices, particularly those like computerized image extraction devices (CIEDs), where there is a chance that the gadget may be reprogrammed or rendered inoperable. The Food and Drug Administration (FDA) of the United States stated in 2023 that Medtronic recalled around 350,000 implantable cardiac devices because of persistent problems with their capacity to provide high-voltage therapy when required.

An advisory on the FDA website states that "a reduced-energy shock, or no shock at all, may fail to correct a life-threatening arrhythmia, which can lead to cardiac arrest, other serious injury, or death." "If a patient with one of these devices requires additional surgical procedures to remove and replace the device, there are additional risks of harm." All cardiac resynchronization therapy defibrillators (CRT-Ds) and implanted cardioverter defibrillators (ICDs) with a glassed feedthrough produced after 2017 are covered by this recall. The use of these devices "may cause serious injuries or death," according to the FDA, which has classified this as a Class I recall. Thus, the market's growth would be somewhat restrained.

The cardiac output monitoring devices market is segmented based on product, type, and end user. The market is segmented into consumables, accessories, and instruments based on product. By type, the cardiac output monitoring devices market is segmented into invasive and non-invasive. End-user segments the cardiac output monitoring devices market into hospitals, ambulatory surgical centers, and others. Based on geography, the cardiac output monitoring devices market is divided into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, South Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Based on geography, the cardiac output monitoring devices market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of cardiac output monitoring devices. This region's growth has been attributed to several factors, including increased investments made by drug development companies, large grants from the US government, a strong presence of major drug development companies, a well-developed healthcare infrastructure, and an increase in chronic diseases.

Based on geography, the cardiac output monitoring devices market is primarily segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. North America is the most significant contributor to the growth of the global market. Regarding the global market for cardiac output monitoring devices, North America held the biggest share in 2021. This can be attributed to the rise in the prevalence of CVDs, the increase in healthcare costs, the increase in disposable income, the rise in health consciousness, and the accessibility of cutting-ed

Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are key primary and secondary sources referred to while preparing the cardiac output monitoring devices report.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Definition, Assumptions and Limitations
  • 1.3 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights
  • 2.2 Market Attractiveness Analysis

3. Research Methodology

4. Cardiac Output Monitoring Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
  • 4.3 Ecosystem Analysis
    • 4.3.1 List of Vendors in the Value Chain

5. Cardiac Output Monitoring Devices Market - Key Market Dynamics

  • 5.1 Key Market Drivers
  • 5.2 Key Market Restraints
  • 5.3 Key Market Opportunities
  • 5.4 Future Trends
  • 5.5 Impact Analysis of Drivers and Restraints

6. Cardiac Output Monitoring Devices Market - Global Market Analysis

  • 6.1 Cardiac Output Monitoring Devices - Global Market Overview
  • 6.2 Cardiac Output Monitoring Devices - Global Market and Forecast to 2030

7. Cardiac Output Monitoring Devices Market - Revenue Analysis (USD Million) - By Products, 2020-2030

  • 7.1 Overview
  • 7.2 Consumables and Accessories
  • 7.3 Instruments

8. Cardiac Output Monitoring Devices Market - Revenue Analysis (USD Million) - By Type, 2020-2030

  • 8.1 Overview
  • 8.2 Invasive
  • 8.3 Non-invasive

9. Cardiac Output Monitoring Devices Market - Revenue Analysis (USD Million) - By End User, 2020-2030

  • 9.1 Overview
  • 9.2 Hospitals
  • 9.3 Ambulatory Surgical Centres
  • 9.4 Others

10. Cardiac Output Monitoring Devices Market - Revenue Analysis (USD Million), 2020-2030 - Geographical Analysis

  • 10.1 North America
    • 10.1.1 North America Cardiac Output Monitoring Devices Market Overview
    • 10.1.2 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts to 2030
    • 10.1.3 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts and Analysis - By Products
    • 10.1.4 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts and Analysis - By Type
    • 10.1.5 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts and Analysis - By End User
    • 10.1.6 North America Cardiac Output Monitoring Devices Market Revenue and Forecasts and Analysis - By Countries
      • 10.1.6.1 United States Cardiac Output Monitoring Devices Market
        • 10.1.6.1.1 United States Cardiac Output Monitoring Devices Market, by Products
        • 10.1.6.1.2 United States Cardiac Output Monitoring Devices Market, by Type
        • 10.1.6.1.3 United States Cardiac Output Monitoring Devices Market, by End User
      • 10.1.6.2 Canada Cardiac Output Monitoring Devices Market
        • 10.1.6.2.1 Canada Cardiac Output Monitoring Devices Market, by Products
        • 10.1.6.2.2 Canada Cardiac Output Monitoring Devices Market, by Type
        • 10.1.6.2.3 Canada Cardiac Output Monitoring Devices Market, by End User
      • 10.1.6.3 Mexico Cardiac Output Monitoring Devices Market
        • 10.1.6.3.1 Mexico Cardiac Output Monitoring Devices Market, by Products
        • 10.1.6.3.2 Mexico Cardiac Output Monitoring Devices Market, by Type
        • 10.1.6.3.3 Mexico Cardiac Output Monitoring Devices Market, by End User

Note - Similar analysis would be provided for below mentioned regions/countries

  • 10.2 Europe
    • 10.2.1 Germany
    • 10.2.2 France
    • 10.2.3 Italy
    • 10.2.4 Spain
    • 10.2.5 United Kingdom
    • 10.2.6 Rest of Europe
  • 10.3 Asia-Pacific
    • 10.3.1 Australia
    • 10.3.2 China
    • 10.3.3 India
    • 10.3.4 Japan
    • 10.3.5 South Korea
    • 10.3.6 Rest of Asia-Pacific
  • 10.4 Middle East and Africa
    • 10.4.1 South Africa
    • 10.4.2 Saudi Arabia
    • 10.4.3 Rest of Middle East and Africa
  • 10.5 South and Central America
    • 10.5.1 Brazil
    • 10.5.2 Argentina
    • 10.5.3 Rest of South and Central America

11. Pre and Post Covid-19 Impact

12. Industry Landscape

  • 12.1 Mergers and Acquisitions
  • 12.2 Agreements, Collaborations, Joint Ventures
  • 12.3 New Product Launches
  • 12.4 Expansions and Other Strategic Developments

13. Competitive Landscape

  • 13.1 Heat Map Analysis by Key Players
  • 13.2 Company Positioning and Concentration

14. Cardiac Output Monitoring Devices Market - Key Company Profiles

  • 14.1 Getinge AB
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments

Note - Similar information would be provided for below list of companies

  • 14.2 GE Healthcare
  • 14.3 ICU Medical, Inc.
  • 14.4 Baxter International Inc.
  • 14.5 Edward Lifesciences Corporation
  • 14.6 LiDCO Group plc
  • 14.7 Deltex Medical Group plc
  • 14.8 Uscom
  • 14.9 Osypka Medical GmbH
  • 14.10 CNSystems Medizintechnik GmbH

15. Appendix

  • 15.1 Glossary
  • 15.2 About The Insight Partners
  • 15.3 Market Intelligence Cloud